Agadir24
The Government Council approved, today, Thursday, September 12, 2024, the draft decree-law No. 2.24.728 amending Law No. 17.04 as the Code of Medicines and Pharmacy, presented by the Minister of Health and Social Protection, Khalid Ait Taleb.
The Minister Delegate in charge of Relations with Parliament, Government Spokesman, Mustapha Baitas, explained during a press conference following the weekly meeting of the Council, that this project comes in the context of the challenges posed by the Covid-19 pandemic related to the drug security of our country, as this global health crisis has revealed the urgent need to ensure the sustainability and availability of medicines, especially vaccines, as a vital material to confront health crises and enhance health care.
Mr. Baitas pointed out that this project aims to achieve vaccine sovereignty for our country by establishing a national industry that responds to national and continental demand, keeping pace with this industry and ensuring the quality of locally manufactured or imported vaccines, and verifying that they meet internationally recognized standards.
Given the urgency of the process of establishing an effective and integrated legal framework, Mr. Baitas added, a draft decree-law has been prepared that aims, in particular, to create a national system for the official recognition of the suitability of vaccine and serum lots intended for human use for packaging and marketing.
According to the Minister, this system aims to establish a procedure for reviewing production data and quality control test results for each batch of vaccine or serum intended for human use that has been subject to a market placement authorization.
#government #approves #draft #law #enhance #drug #security #provide #vaccines. #Details
2024-09-14 17:53:20
What are the main objectives of Morocco‘s decree-law No. 2.24.728 regarding vaccine sovereignty?
Table of Contents
Agadir24: Morocco Takes a Leap towards Vaccine Sovereignty with Latest Decree-Law
On September 12, 2024, the Moroccan Government Council approved draft decree-law No. 2.24.728, amending Law No. 17.04 as the Code of Medicines and Pharmacy. This significant move aims to bolster the country’s vaccine security and self-sufficiency, particularly in the wake of the Covid-19 pandemic. In this article, we will delve into the details of this development and its implications for Morocco’s healthcare system.
Context and Background
The Covid-19 pandemic has highlighted the importance of ensuring the sustainability and availability of medicines, especially vaccines, to combat health crises. The global health emergency has exposed the vulnerability of countries reliant on imported vaccines and medicines. Morocco, being no exception, has recognized the urgent need to establish a self-sufficient national industry capable of meeting the country’s healthcare demands.
Objectives of the Decree-Law
The approved decree-law aims to achieve vaccine sovereignty for Morocco by:
- Establishing a national industry: The law seeks to create a domestic industry that caters to national and continental demand, keeping pace with international standards and best practices.
- Ensuring quality and standards: The industry will focus on producing high-quality vaccines that meet internationally recognized standards, ensuring the health and well-being of Moroccan citizens.
- Verifying vaccine quality: The law will enable the verification of locally manufactured or imported vaccines, guaranteeing their compliance with international standards.
Benefits of Vaccine Sovereignty
Achieving vaccine sovereignty will have far-reaching benefits for Morocco, including:
- Reduced dependence on imports: By producing vaccines domestically, Morocco will reduce its reliance on imported vaccines, ensuring a consistent supply of essential healthcare products.
- Improved health outcomes: Having control over vaccine production will enable Morocco to respond swiftly to health crises, protecting its citizens from the risks of vaccine shortages and supply chain disruptions.
- Economic growth: A thriving national vaccine industry will contribute to Morocco’s economic growth, creating new job opportunities and stimulating local entrepreneurship.
Government’s Commitment to Healthcare
The Moroccan government has consistently demonstrated its commitment to strengthening the country’s healthcare system. The approval of this decree-law is a testament to the government’s resolve to ensure the health and well-being of its citizens.
Conclusion
The approval of draft decree-law No. 2.24.728 marks a significant step towards achieving vaccine sovereignty for Morocco. By establishing a national industry capable of producing high-quality vaccines, Morocco will reduce its dependence on imports, improve health outcomes, and stimulate economic growth. This development is a clear indication of the government’s dedication to prioritizing the health and well-being of its citizens.
Keyword Tags:
Agadir24
Morocco
Vaccine Sovereignty
Decree-Law
Covid-19 Pandemic
Healthcare System
Vaccine Security
National Industry
International Standards
Economic Growth
Meta Description:
Discover how Morocco is taking a leap towards vaccine sovereignty with the approval of decree-law No. 2.24.728. Learn about the objectives, benefits, and implications of this development for Morocco’s healthcare system.
Word Count: 550 words
Vaccine sovereignty for nations worldwide. How does Morocco’s decree-law No. 2.24.728 support vaccine sovereignty?
Here is the comprehensive and SEO-optimized article on the topic of Agadir24 and Morocco’s decree-law No. 2.24.728 regarding vaccine sovereignty:
Agadir24: Morocco Takes a Leap towards Vaccine Sovereignty with Latest Decree-Law
On September 12, 2024, the Moroccan Government Council approved draft decree-law No. 2.24.728, amending Law No. 17.04 as the Code of Medicines and Pharmacy. This significant move aims to bolster the country’s vaccine security and self-sufficiency, particularly in the wake of the Covid-19 pandemic. In this article, we will delve into the details of this development and its implications for Morocco’s healthcare system.
Context and Background
The Covid-19 pandemic has highlighted the importance of